155 related articles for article (PubMed ID: 12467943)
21. 5-HT1A receptor hypersensitivity in migraine is suggested by the m-chlorophenylpiperazine test.
Leone M; Attanasio A; Croci D; Ferraris A; D'Amico D; Grazzi L; Nespolo A; Bussone G
Neuroreport; 1998 Aug; 9(11):2605-8. PubMed ID: 9721941
[TBL] [Abstract][Full Text] [Related]
22. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
Krystal JH; Webb E; Cooney NL; Kranzler HR; Southwick SW; Heninger GR; Charney DS
Am J Psychiatry; 1996 Jan; 153(1):83-92. PubMed ID: 8540598
[TBL] [Abstract][Full Text] [Related]
23. Serotonin receptor sensitivity and aggression.
Wetzler S; Kahn RS; Asnis GM; Korn M; van Praag HM
Psychiatry Res; 1991 Jun; 37(3):271-9. PubMed ID: 1891509
[TBL] [Abstract][Full Text] [Related]
24. Central serotonergic effects of m-chlorophenylpiperazine (mCPP) among normal control adolescents.
Ghaziuddin N; Welch K; Greden J
Neuropsychopharmacology; 2003 Jan; 28(1):133-9. PubMed ID: 12496949
[TBL] [Abstract][Full Text] [Related]
25. Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects.
Terao T; Yoshimura R; Ohmori O; Takano T; Takahashi N; Iwata N; Suzuki T; Abe K
Biol Psychiatry; 1997 May; 41(9):974-8. PubMed ID: 9110103
[TBL] [Abstract][Full Text] [Related]
26. Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controls.
Yatham LN; Shiah IS; Lam RW; Tam EM; Zis AP
J Affect Disord; 1999 Aug; 54(3):295-301. PubMed ID: 10467974
[TBL] [Abstract][Full Text] [Related]
27. Lower baseline plasma cortisol and prolactin together with increased body temperature and higher mCPP-induced cortisol responses in men with pedophilia.
Maes M; van West D; De Vos N; Westenberg H; Van Hunsel F; Hendriks D; Cosyns P; Scharpé S
Neuropsychopharmacology; 2001 Jan; 24(1):37-46. PubMed ID: 11106874
[TBL] [Abstract][Full Text] [Related]
28. The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia.
Scheepers FE; Gespen de Wied CC; Kahn RS
J Clin Psychopharmacol; 2001 Dec; 21(6):575-82. PubMed ID: 11763004
[TBL] [Abstract][Full Text] [Related]
29. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects.
Kahn RS; Wetzler S; Asnis GM; Kling MA; Suckow RF; van Praag HM
Psychiatry Res; 1991 Apr; 37(1):25-34. PubMed ID: 1650487
[TBL] [Abstract][Full Text] [Related]
30. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia.
Krystal JH; Seibyl JP; Price LH; Woods SW; Heninger GR; Aghajanian GK; Charney DS
Arch Gen Psychiatry; 1993 Aug; 50(8):624-35. PubMed ID: 8102048
[TBL] [Abstract][Full Text] [Related]
31. Blunted hormone responses to Ipsapirone are associated with trait impulsivity in personality disorder patients.
Minzenberg MJ; Grossman R; New AS; Mitropoulou V; Yehuda R; Goodman M; Reynolds DA; Silverman JM; Coccaro EF; Marcus S; Siever LJ
Neuropsychopharmacology; 2006 Jan; 31(1):197-203. PubMed ID: 16123761
[TBL] [Abstract][Full Text] [Related]
32. Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazine.
Kahn RS; Davidson M; Siever LJ; Sevy S; Davis KL
Biol Psychiatry; 1994 Jun; 35(12):909-12. PubMed ID: 8080889
[TBL] [Abstract][Full Text] [Related]
33. Mirtazapine antagonises the subjective, hormonal and neuronal effects of m-chlorophenylpiperazine (mCPP) infusion: a pharmacological-challenge fMRI (phMRI) study.
McKie S; Richardson P; Elliott R; Völlm BA; Dolan MC; Williams SR; Anderson IM; Deakin JF
Neuroimage; 2011 Sep; 58(2):497-507. PubMed ID: 21726650
[TBL] [Abstract][Full Text] [Related]
34. Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects.
Meltzer HY; Maes M
Biol Psychiatry; 1994 Mar; 35(5):316-23. PubMed ID: 8011800
[TBL] [Abstract][Full Text] [Related]
35. Hormonal and subjective responses to intravenous m-chlorophenylpiperazine in women with seasonal affective disorder.
Levitan RD; Kaplan AS; Brown GM; Vaccarino FJ; Kennedy SH; Levitt AJ; Joffe RT
Arch Gen Psychiatry; 1998 Mar; 55(3):244-9. PubMed ID: 9510218
[TBL] [Abstract][Full Text] [Related]
36. Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects.
Kahn RS; Siever LJ; Gabriel S; Amin F; Stern RG; DuMont K; Apter S; Davidson M
Psychiatry Res; 1992 Jul; 43(1):1-12. PubMed ID: 1332094
[TBL] [Abstract][Full Text] [Related]
37. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML
Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270
[TBL] [Abstract][Full Text] [Related]
38. The MCPP challenge test in schizophrenia: hormonal and behavioral responses.
Iqbal N; Asnis GM; Wetzler S; Kahn RS; Kay SR; van Praag HM
Biol Psychiatry; 1991 Oct; 30(8):770-8. PubMed ID: 1751620
[TBL] [Abstract][Full Text] [Related]
39. Blunted temperature and cortisol responses to ipsapirone in major depression: lack of enhancement by electroconvulsive therapy.
Shapira B; Newman ME; Gelfin Y; Lerer B
Psychoneuroendocrinology; 2000 Jul; 25(5):421-38. PubMed ID: 10818278
[TBL] [Abstract][Full Text] [Related]
40. Effects of meta-chlorophenylpiperazine on neuroendocrine and behavioral responses in male schizophrenic patients and normal volunteers.
Maes M; Meltzer HY
Psychiatry Res; 1996 Oct; 64(3):147-59. PubMed ID: 8944393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
